Justin Walsh
Stock Analyst at Jones Trading
(3.90)
# 655
Out of 5,122 analysts
39
Total ratings
37.84%
Success rate
18.59%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Beckley | Initiates: Buy | $16 | $3.98 | +302.01% | 1 | Dec 23, 2025 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | $61 | $12.95 | +371.04% | 1 | Dec 23, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $83 | $297.02 | -72.06% | 1 | Sep 18, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $109 → $84 | $67.16 | +25.07% | 10 | Sep 16, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $3 | $0.25 | +1,096.17% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $2.87 | +318.12% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $5.96 | +403.36% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $65.07 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $2.01 | +446.99% | 1 | Mar 11, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $18 | $17.94 | +0.33% | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $30.64 | +37.10% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $2.74 | +702.92% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.63 | +141.33% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.70 | +325.53% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $0.66 | +510.50% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.44 | +481.40% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $360 | $12.53 | +2,773.10% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $440 | $1.16 | +37,831.03% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.54 | +13,694.37% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $50.02 | -60.02% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $1.01 | +19,701.98% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $5.38 | +85.87% | 1 | Jan 19, 2022 |
Atai Beckley
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $3.98
Upside: +302.01%
Mind Medicine (MindMed)
Dec 23, 2025
Initiates: Buy
Price Target: $61
Current: $12.95
Upside: +371.04%
Praxis Precision Medicines
Sep 18, 2025
Initiates: Buy
Price Target: $83
Current: $297.02
Upside: -72.06%
Lantheus Holdings
Sep 16, 2025
Maintains: Buy
Price Target: $109 → $84
Current: $67.16
Upside: +25.07%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.25
Upside: +1,096.17%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $2.87
Upside: +318.12%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $5.96
Upside: +403.36%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $65.07
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $2.01
Upside: +446.99%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $17.94
Upside: +0.33%
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $30.64
Upside: +37.10%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $2.74
Upside: +702.92%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $6.63
Upside: +141.33%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $4.70
Upside: +325.53%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.66
Upside: +510.50%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $3.44
Upside: +481.40%
May 16, 2023
Initiates: Buy
Price Target: $360
Current: $12.53
Upside: +2,773.10%
Feb 10, 2023
Initiates: Buy
Price Target: $440
Current: $1.16
Upside: +37,831.03%
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $0.54
Upside: +13,694.37%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $50.02
Upside: -60.02%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $1.01
Upside: +19,701.98%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $5.38
Upside: +85.87%